Vas Narasimhan, global head of drug development and chief medical officer for Novartis, explains the clinical trial that's underway.
Novartis Exec: We Are One Step Closer to Beating Malaria
Comment
Show comments
Hide Comments
Vas Narasimhan, global head of drug development and chief medical officer for Novartis, explains the clinical trial that's underway.
